This trial is to study if it's possible to do aerobic and resistance exercises for people with GVHD.
1 Primary · 14 Secondary · Reporting Duration: Evaluated at week 1 at baseline and week 7 on treatment, and at week 13 post-treatment also at week 25 follow-up
Experimental Treatment
36 Total Participants · 2 Treatment Groups
Primary Treatment: Exercise · No Placebo Group · N/A
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: